CDMO
Product Description
Zentiva
-
CZ
-
2019On CPHI since
Zentiva
-
CZ
-
2019On CPHI since
More Products from Zentiva (4)
-
Product Zent2U - Zentiva B2B Platform
Zent2U (www.zent2u.com) is a B2B platform of Zentiva established in 2019 to collaborate with customers on:
- Licensing-out dossiers developed by Zentiva
- Co-development opportunities by co-financing Zentiva's products in development
- CMO services by Zentiva in production ... -
Product Value Added Dasatinib
Value added Dasatinib (Teaser attached) • Dasatinib is a targeted therapy used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) • Current available products on the market are not completely absorbed by those patients ... -
Product Value Added Abiraterone
Value added Abiraterone • Abiraterone is a medication used to treat prostate cancer • The recommended dose is 1,000 mg as a single daily dose that must not be taken with food. • Administering with food results up to a 10-fold (AUC) and up to a 17-fo... -
Product Innovative combination Finasteride + Tadalafil
Innovative combination Finasteride + Tadalafil • Both products individually are approved for BPH (Benign prostatic hyperplasia) in Europe. • The most frequent adverse reactions are impotence and decreased libido in Finasteride. The benefit of Tadalafil is early onset of the...
Zentiva resources (1)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance